A prospective study: the curative effect of LUTS/BPH individualized treatment

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-PRCH-14004195

Enrollment

Unknown

Registered

2014-01-24

Start date

2014-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostate hyperplasia

Interventions

drug/surgical treatment:drug/surgical treatment

Eligibility

Sex/Gender

Male

Age

50 Years to 90 Years

Inclusion criteria

Inclusion criteria: BPH/LUTS

Exclusion criteria

Exclusion criteria: Drug treatment exclusion criteria: (1)neurogenic bladder dysfunction, urinary tract infection, prostatitis, urethral stricture, bladder tumor, bladder or lower segment ureteral calculi, etc; (2) once received urethra or prostate surgery; (3) there is the absolute indications for surgery. Surgical exclusion criteria: (1) the Qmax > 20 ml/s; (2) neurogenic bladder dysfunction; (3) the history of urinary tract injury or once received or urethra prostate surgery; (4) confirmed with bladder calculi, tumors or cancer of the prostate; (5) confirmed urethral stricture or bladder neck contracture; (6) preoperative without at least 6 months of alpha blockers and 5 alpha reductase inhibitors combination therapy.

Design outcomes

Primary

Measure	Time frame
effecacy;	—

Countries

China

Contacts

Public ContactQi Jun

Xinhua Hospital affiliated to Shanghai Jiaotong University, School of Medicine

jasonqi@sh163.net+86 13901817928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026